The rate of patients that achieved an HbA1c <7.0% without developing clinically significant or severe hypoglycemia events at week 26 were significantly higher in patients receiving insulin icodec rather than the control (37% vs. 27%; estimated odds ratio = 1.59; 95%CI: 1.07 to 2.36). Here, INS is linked to Hypoglycemia.